Hemken, Philip M.
Qin, Xuzhen
Sokoll, Lori J.
Jackson, Laurel
Feng, Fan
Li, Peng
Gawel, Susan H.
Tu, Bailin
Lin, Zhihong
Hartnett, James
Hawksworth, David
Tieman, Bryan C.
Yoshimura, Toru
Kinukawa, Hideki
Ning, Shaohua
Liu, Enfu
Meng, Fanju
Chen, Fei
Miao, Juru
Mi, Xuan
Tong, Xin
Chan, Daniel W.
Davis, Gerard J.
Funding for this research was provided by:
Abbott Laboratories
National High Level Hospital Clinical Research Funding (2022-PUMCH-A-059, 2022-PUMCH-B-124)
Article History
Received: 11 August 2023
Accepted: 13 November 2023
First Online: 28 November 2023
Declarations
:
: The specimen utilization for Johns Hopkins specimens for use in this study was approved by the Johns Hopkins Medicine IRB. For the research validation specimen cohort, this study was approved by the PUMCH IRB (HS-2386).
: Not applicable.
: Philip M. Hemken is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; Xuzhen Qin receives research funding support from Abbott Laboratories to Peking Union Medical College Hospital; Lori J. Sokoll receives research funding support from Abbott Laboratories to Johns Hopkins University; Laurel Jackson is an employee of Abbott Laboratories; Fan Feng is an employee of and owns stock in Abbott Laboratories; Peng Li receives research funding support from Abbott Laboratories to Peking Union Medical College Hospital; Susan H. Gawel is an employee of, owns stock in, receives research funding support from, and holds intellectual property interests with Abbott Laboratories; Bailin Tu is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; Zhihong Lin is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; James Harnett is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; David Hawksworth is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; Bryan C. Tieman is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; Toru Yoshimura is an employee of, owns stock in, and holds intellectual property interests with Abbott Laboratories; Hideki Kinukawa is an employee of and owns stock in interests with Abbott Laboratories; Shaohua Ning is an employee of Abbott Laboratories; Enfu Liu is an employee of Abbott Laboratories; Fanju Meng is an employee of Abbott Laboratories; Fei Chen is an employee of Abbott Laboratories; Juru Miao is an employee of Abbott Laboratories; Xuan Mi is an employee of Abbott Laboratories; Xin Tong is an employee of Abbott Laboratories; Daniel W. Chan receives research funding support from Abbott Laboratories to Johns Hopkins University; Gerard J. Davis is an employee of, owns stock in, receives research funding support, and holds intellectual property interests with Abbott Laboratories.